Clinical Trial Update: Safety and Efficacy of SIMBRINZA® BID as an Adjunctive to DUOTRAV® [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating SIMBRINZA® as an adjunctive therapy to DUOTRAV® in open-angle glaucoma and ocular hypertension, terminated with results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• DuoTrav (travoprost; timolol (fixed-dose combination))
• Simbrinza (brinzolamide/brimonidine)

Snippet

Sponsor: Alcon Research | Conditions: Open-angle Glaucoma, Ocular Hypertension | Phase 4 | Status: TERMINATED | Results posted: 2019-05-17